Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|June 15, 2007
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32)S Werwitzke, D Trick, P Sondermann, et al.
NMR in Biomedicine|October 13, 2016
Fast diffusion kurtosis imaging of fibrotic mouse kidneysB F Kjølby, A R Khan, A Chuhutin, et al.
Rheumatology International|April 25, 2000
Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study groupT Witte, K Hartung, C Sachse, et al.
The Journal of Clinical Investigation|September 1, 1993
Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosusT Witte, F L Dumoulin, J E Gessner, et al.
Deutsche Medizinische Wochenschrift (1946)|June 6, 2009
[Autoantibody detection by indirect immunofluorescence on HEp-2 cells]U Sack, K Conrad, E Csernok, et al.
Analytical Chemistry|November 16, 2005
Net analyte signal based statistical quality controlE T S Skibsted, H F M Boelens, J A Westerhuis, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activityG Zandman-Goddard, M Blank, P Langevitz, et al.
European Journal of Immunology|October 28, 1997
Double-positive T cell receptor(high) thymocytes are resistant to peptide/major histocompatibility complex ligand-induced negative selectionY Ghendler, R E Hussey, T Witte, et al.
Genes and Immunity|April 9, 2005
Association of multiple sclerosis with ILT6 deficiencyS Koch, R Goedde, V Nigmatova, et al.
Rheumatology International|October 23, 1998
Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study GroupT Witte, K Hartung, T Matthias, et al.
Pageof 20